相关实验视频
Updated: Jun 3, 2025

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
1.6K
概括
免疫检查点抑制剂 (ICI) 可以引起甲状腺免疫相关的不良事件 (irAEs),通常呈现为甲状腺毒性,随后是甲状腺功能低下症. 对于接受癌症免疫治疗的患者来说,早期检测和管理至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 免疫检查点抑制剂 (ICI) 是广泛使用的癌症疗法.
- 与免疫相关的不良事件 (irAEs) 是ICI的常见副作用.
- 甲状腺激发性瘤是最常见的内分泌激发性瘤,影响8.9-22.2%的患者.
研究的目的:
- 总结甲状腺irAEs的临床特征,危险因素和治疗方法.
- 突出甲状腺IRAE与某些癌症的良好预后之间的关联.
- 强调需要精细的管理策略,特别是与ICI疗法的结合.
主要方法:
- 关于ICI诱导的甲状腺激动性瘤的临床数据和文献的综述.
- 对发病率,临床表现和风险因素的分析.
- 评估当前和拟议的管理策略.
主要成果:
- 甲状腺irrAEs通常由抗PD-1/PD-L1抗体触发,呈现双相甲状腺功能障碍.
- 风险因素包括甲状腺自身抗体,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG-PET吸收,18F-FDG吸收,18F-FDG吸收,18F-FDG吸收,18F-FDG吸收,18F-FDG吸收,18F-FDG吸收,18F-FDG吸收.
- 甲状腺IRAE与非小细胞肺癌的良好预后有关.
结论:
- 在ICI治疗期间,早期和定期监测甲状腺功能是必不可少的.
- 甲状腺功能低下症需要立即接受levothyroxine治疗,而甲状腺毒素症可能只需要观察.
- 管理策略必须适应不断变化的ICI组合疗法和联合使用的药物.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Synthesis and Regulation of Thyroid Hormones
4.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.2K
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Autoimmune Disorders
385
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
385
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233

